|
FY2022
12 months to Dec 31, 2022
|
FY2021
7 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Change in fair value of derivative liability | ||
| Financing expense on derivative liability | ||
| Investment income on marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Accounts payable and accrued expenses | ||
| Prepaid expenses | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Investment of cash into Trust Account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from initial public offering, net of costs | ||
| Proceeds from Private Placement Shares | ||
| Proceeds from issuance of promissory payable - related party | ||
| Payment of promissory note payable - related party | ||
| Payments of deferred offering costs included in accrued expenses | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash, beginning of the period | ||
| Cash, end of the period | ||
| Supplemental disclosure of noncash financing activities: | ||
| Deferred underwriters fee charged to additional paid-in capital | ||
| Deferred underwriting discounts and commissions | ||
| Accretion of Class A ordinary shares redemption value | ||
| Waiver of deferred underwriting discounts and commissions |
Loading...
